SVB Leerink analyst Mani Foroohar maintains Moderna (NASDAQ:MRNA) with a Underperform and raises the price target from $85 to $86.
Itau BBA Upgrades Ternium to Outperform, Announces $70 Price Target
Itau BBA upgrades Ternium (NYSE:TX) from Market Perform to Outperform and announces $70 price target.